Friday April 25, 2014




Home »  News »  Business

Actavis and Warner Chilcott say they are in early discussions about a possible combination


This photo provided by Actavis shows the company's logo. Drugmakers Actavis Inc. and Warner Chilcott PLC said Friday, May 10, 2013, that they are in early talks about a possible combination of the two companies. Both say there is no agreement on a deal yet. (AP Photo/Actavis)

NEW YORK, N.Y. - Drugmakers Actavis Inc. and Warner Chilcott PLC said Friday that they in early talks about a possible combination of the two companies. Both say there is no agreement on a deal yet.

Shares of both companies soared in Friday trading.

Actavis was formed in October through a $5.6 billion combination of Watson Pharmaceuticals of New Jersey and Actavis of Switzerland. It is one of the world's biggest generic drug companies. It sells versions of the deep vein thrombosis treatment Lovenox, asthma medication Xopenex, attention deficit hyperactivity disorder drugs Adderall XR and Concerta, heart drug Toprol XL, cholesterol fighter Lipitor, contraceptive Generess FE, and pain drug Kadian among many other products.

Actavis also has a pharmaceutical distribution business called Anda.

Warner Chilcott is based in Ireland. The company's sales declined over the last two years after low-cost generic versions of its osteoporosis drug Actonel went on sale in Western Europe and Canada in 2010. At the same time, sales of drugs like Actonel have fallen in the U.S. The company expects sales to keep slipping in 2013.

Other Warner Chilcott products include the ulcerative colitis treatment Asacol, which is its top-selling drug, and Delzicol, an ulcerative colitis medication that was approved in February. The company also sells oral contraceptives including Lo Loestrin FE.

Actavis expects to generate more than $8.1 billion in revenue this year, while Warner Chilcott expects $2.3 billion to $2.4 billion. Actavis, based in Parsippany, N.J., had 17,700 employees as the end of 2012, while Warner Chilcott had 2,100.

Warner Chilcott shares climbed $3, or 20 per cent, to close at $18.01. According to FactSet, the company's market capitalization stood at $3.76 billion as of Thursday's close and rose to about $4.51 billion on Friday.

Actavis shares rose $13.05, or 12.2 per cent, to close at $119.86 after reaching an all-time high of $121.13.


Comments


NOTE: To post a comment in the new commenting system you must have an account with at least one of the following services: Disqus, Facebook, Twitter, Yahoo, OpenID. You may then login using your account credentials for that service. If you do not already have an account you may register a new profile with Disqus by first clicking the "Post as" button and then the link: "Don't have one? Register a new profile".

The Yorkton This Week welcomes your opinions and comments. We do not allow personal attacks, offensive language or unsubstantiated allegations. We reserve the right to edit comments for length, style, legality and taste and reproduce them in print, electronic or otherwise. For further information, please contact the editor or publisher, or see our Terms and Conditions.

blog comments powered by Disqus


Quick Vote

Survey results are meant for general information only, and are not based on recognised statistical methods.


Markets





LOG IN



Lost your password?